InsidersTradesSigma
东北制药 Stock: price and management transactions · China · SSE / SZSE (CSRC)
Follow the 东北制药 share price and the full management transaction log of the company, a listed equity based in China. Shares trade on CN CN, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 东北制药 has published 9 reports. Market capitalisation: €7.4bn. The latest transaction was disclosed on 31 May 2022 (Purchase). Among the most active insiders: 郑伟. Every trade is free.
9
Insider Decl.
0
Thresholds
·
9 ops.
Buy Volume
·
0 ops.
Sell Volume
25Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 10,174 of 26,212 companies
57.5
score / 100
Value70
Quality45
FCF yld16%
Earn yld4.1%
EV/EBITDA9.5x
ROE3.5%
Gross mgn37%
Net mgn3.7%
Debt/EBITDA2.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 31 May 2022
Declarations9 total
9 of 9 declarations